FindTrial
Sign In

To study outcome parameters in a specific cancer AdCC(Adenoid Cystic carcinoma) of Head and Neck region.

Predictors of clinical outcomes in Adenoid Cystic Carcinoma of Head and Neck : An Ambispective Analysis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/081124
Enrollment
100
Registered
2025-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Control Intervention1: NIL: NIL

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor
Dr Kapil Sikka
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Histologically proven Adenoid Cystic Carcinoma. Site - Head and neck region. Subsites - Nose, PNS, Orbit, Ear, Oral cavity, Pharynx, Larynx, Salivary Glands. Stage- I to IV as per AJCC 8th edition. Treated by any of the modalities at AIIMS or NCI JAJJHAR from JAN. 2014 till DEC. 2025.

Exclusion criteria

Exclusion criteria: Non Adenoid Cystic Histology. Patient not giving consent.

Design outcomes

Primary

MeasureTime frame
Survival Outcomes - OS(Overall Survival), LRRFS(Loco-Regional Recurrence Free Survival), DFS(Disease Free Survival).Timepoint: At 3 months—

Secondary

MeasureTime frame
QOL(Quality Of Life)Timepoint: 3 months—

Countries

India

Contacts

Public ContactDr. Dinesh Kumar Sharma

AIIMS, New Delhi.

kapil_sikka@yahoo.com9810423088

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026